First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

NCT01371201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)

Interventions

DRUG: Sunitinib
DRUG: Placebo

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]
[object Object]